Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Lau; Cheuk Kun
Address:
Ile Bizard, CA
No. of patents:
10
Patents:












Patent Number Title Of Patent Date Issued
6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) June 24, 2003
The invention encompasses the novel class of compounds represented by formula I which are inhibitors of the PTP-1B enzyme. ##STR1##The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, a
6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors December 24, 2002
The invention encompasses the novel class of compounds represented by the formula below, which are inhibitors of the PTP-1B enzyme. ##STR1##The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes.
6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) November 26, 2002
The invention encompasses the novel class of compounds represented by formula I, which are inhibitors of the PTP-1B enzyme. ##STR1##The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity,
6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) November 26, 2002
The invention encompasses the novel class of compounds represented by formula I which are inhibitors of the PTP-1B enzyme. ##STR1##The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, a
6465509 Pyrones as inhibitors of cyclooxygenase-2 October 15, 2002
The invention encompasses the novel compounds of Formula I, which are useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1##The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods of treating cyclooxygen
6169188 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors January 2, 2001
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1##The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
6020343 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors February 1, 2000
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula
5981576 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors November 9, 1999
The invention encompasses the novel compound of Formula A that is useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of
5677318 Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents October 14, 1997
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention al
5639780 N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors June 17, 1997
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula










 
 
  Recently Added Patents
Metal foil laminate, substrate for mounting LED, and light source device
Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human
System and method for providing definitions
Mobile terminal based on W-CDMA system having receive diversity function and system thereof
Emergency power-off button with proximity alarm
Herbal composition for the treatment of wound healing, a regenerative medicine
Method to alter silicide properties using GCIB treatment
  Randomly Featured Patents
Discharge lamps
Method and apparatus to improve closed loop transmit diversity modes performance via interference suppression in a WCDMA network equipped with a rake receiver
Small animal light intensity monitor
Extension and locking assembly for dripless element and container therefore
Control apparatus for use in a power transmission system of construction vehicles
Enhancement of digital images for electronic displays
Insecticidal proteins derived from Bacillus thuringiensis
Information terminal, computer resource managing method, and virtual machine execution switching method
Techniques for secure network communication
Heavy duty truck suspension with drive axle